BFLY
Next earnings: Jul 31, 2026 · Before open
Signal
Leaning Bullish1
Price
1
Move-0.10%Quiet session
Volume
1
Volume0.7× avgNormal activity
Technical
1
RSIRSI 52Momentum positive
PRICE
Prev Close
4.85
Open
4.90
Day Range4.81 – 5.02
4.81
5.02
52W Range1.32 – 5.72
1.32
5.72
80% of range
VOLUME & SIZE
Avg Volume
6.0M
FUNDAMENTALS
P/E Ratio
-16.1x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
2.14
High vol
Performance
1D
-10.19%
5D
-5.64%
1M
+17.43%
3M
+32.15%
6M
+85.11%
YTD
+27.63%
1Y
+118.47%
Best: 1Y (+118.47%)Worst: 1D (-10.19%)
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +20% YoY · 49% gross margin
Valuation
FAIR
P/E not available
Health
MODERATE
CR 4.0 · FCF negative
Bullish
Key MetricsTTM
Market Cap$1.27B
Revenue TTM$102.92M
Net Income TTM-$75.77M
Free Cash Flow-$18.86M
Gross Margin49.2%
Net Margin-73.6%
Operating Margin-79.1%
Return on Equity-36.8%
Return on Assets-26.5%
Debt / Equity0.10
Current Ratio4.02
EPS TTM$-0.30

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
3 strong3 concern
50/100
Liquidity
4.02Strong
Leverage
0.10Strong
Coverage
-57.3xConcern
ROE
-36.8%Concern
ROIC
-35.5%Concern
Cash
$150MStrong
ANALYST COVERAGE7 analysts
BUY
+13.5%upside to target
L $5.25
Med $5.50consensus
H $5.50
Buy
686%
Hold
114%
6 Buy (86%)1 Hold (14%)0 Sell (0%)
Full report →
Stock Health
Composite Score
5 of 5 signals bullish
10/10
Technicals
RSI RangeRSI 52 — Bullish momentum
Volume
Volume FlowAccumulation — institutional buying
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 4.02 — healthy liquidity
Upcoming Events
EEarnings ReportMay 6, 2026
Tomorrow
DEx-Dividend DateAug 3, 2026
In 90 days
PDividend PaymentAug 20, 2026
In 107 days
Technicals
Technical SetupBULLISH
Technicals →

Trend

UptrendGolden Cross · 50D leads 200D by 53.4%

+14.0% vs SMA 50 · +74.8% vs SMA 200

Momentum

RSI51.9
Neutral territory
MACD+0.33
Above zero — bullish momentum · compressing
Market Position
Price Levels
52W High
$5.72+18.1%
Current
$4.84
EMA 50
$4.33-10.5%
EMA 200
$2.96-38.8%
52W Low
$1.32-72.8%
52-Week RangeNear 52-week high
$1.3280th %ile$5.72
Squeeze SetupVolume-based
Moderate Squeeze Setup

Accumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.

20-Day Money Flow
Acc days:5
Dist days:3
Edge:+2 acc
Volume Context
Avg Vol (50D)3.8M
Recent Vol (5D)
3.6M-7%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 3 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2025
$91.8M
$89.0M$96.0M
-$0.17
±5%
Moderate3
FY2026(current)
$118.8M
$115.2M$124.2M
+29.4%-$0.13
±5%
Moderate3
FY2027
$142.3M
$138.0M$148.8M
+19.8%-$0.09
±5%
Moderate3
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryBFLY
Last 8Q
+14.8%avg beat
Beat 7 of 8 quartersMissed 1 Estimates rising
+50%
Q3'24
+20%
Q4'24
+11%
Q1'25
+33%
Q2'25
+14%
Q3'25
-86%
Q4'25
+50%
Q1'26
+25%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Insider Activity
SEC Filings →
0 Buys/6 SellsNet Selling
NET SELLERS$0 bought · $1.8M sold · 30d window
Cashman SteveChief Business…
$724K
Apr 29
SELL
Cashman SteveChief Business…
$1.0M
Apr 16
SELL
Devivo JosephDir
$1.8M
Mar 5
SELL
Cashman SteveChief Business…
$158K
Mar 3
SELL
Devivo JosephDir
$599K
Mar 3
SELL
Caezza NicholasDeputy General…
$53K
Mar 3
SELL
Financials

INSTITUTIONAL OWNERSHIP

1
Nuveen, LLC
3.7M
2
PERKINS CAPITAL MANAGEMENT INC
931K
3
ISTHMUS PARTNERS, LLC
689K
4
OPPENHEIMER & CO INC
328K
5
Quent Capital, LLC
209K
6
Green Alpha Advisors, LLC
170K
7
COMMONWEALTH EQUITY SERVICES, LLC
147K
8
Counterpoint Mutual Funds LLC
135K
News & Activity

BFLY News

20 articles · 4h ago

About

Founded by Dr. Jonathan Rothberg in 2011, Butterfly has created the world's first handheld, single-probe whole-body ultrasound system using its patented Ultrasound-on-Chip™ semiconductor technology. Butterfly's mission is to democratize medical imaging and contribute to the aspiration of global health equity, including for the 4.7 billion people around the world lacking access to ultrasound. Butterfly is paving the way for earlier detection and remote management of health conditions around the world. The Butterfly iQ can be purchased today by healthcare practitioners in the United States, Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, New Zealand, Norway, Poland, Portugal, Spain, Sweden, Switzerland, and the United Kingdom. Butterfly iQ is a prescription device intended for trained and qualified healthcare professionals only.

Industry
Irradiation Apparatus Manufacturing
John N. DohertyExecutive VP & CFO
Mercedes KelemenVice President of Human Resources
Jason HeimSenior Vice President of US Sales
PeersHealth Care(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
BFLY
$4.84-10.19%$1.3B+1895.5%-7895.1%1500
$68.92+0.00%$13.4B1500
$89.41+0.00%$12.0B-4239.0%1500
$503.08+0.96%$11.9B-3008.0%1500
$223.70+8.31%$11.4B+6554.5%-2868.8%1500
$74.58+0.00%$10.7B52.9+2325815.3%-19.7%1500
$175.51+0.00%$10.6B1500
Sector avg-0.13%52.9+778088.4%-3606.1%1500